Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0122459 METHOD FOR PRODUCING POLYACETAL COPOLYMER
A high-quality polyacetal copolymer produced by a simple process in an economical manner. The process includes supplying a raw material including trioxane and...
2016/0122458 GENERATION OF AMPHIPHILIC NETWORK WITH AN ABILITY TO DISTINGUISH THE TRANSPORT OF IGG AND INSULIN
A method of preparing an amiphiphilic co-network comprising preparing a molecularly-bimodal crosslinkable amphiphilic graft by polymerizing a ...
2016/0122457 NITRILE GROUP-CONTAINING COPOLYMER RUBBER, CROSS-LINKABLE RUBBER COMPOSITION, AND CROSS-LINKED RUBBER
A nitrile group-containing copolymer rubber which has a hydroxyl group, carboxyl group, or carbon-carbon double bond at an end carbon atom or on a carbon atom...
2016/0122456 PHOTORESIST COMPOSITIONS AND METHOD OF PREPARING THE SAME
The present invention provides a photoresist composition and a method of preparing the same. The photoresist composition includes a color polymer that is...
2016/0122455 METAL COMPLEX WITH A BRIDGED CYCLOPENTADIENYL AMIDINE LIGAND
The present invention relates to a new metal complex of the formula (1) ##STR00001## wherein: M is a group 4-6 metal R.sup.1 means is a substituent comprising...
2016/0122454 Polymers With Improved Toughness and ESCR for Large-Part Blow Molding Applications
Disclosed herein are ethylene-based polymers having a density greater than 0.945 g/cm.sup.3, a high load melt index less than 25 g/10 min, a peak molecular...
2016/0122453 Methods of Catalyst Activation
A method comprising preparing a multi-component catalyst system comprising a catalyst and a cocatalyst, and adjusting the level of at least one component of...
2016/0122452 Ethylene-Propylene Copolymeric Compositions With Long Methylene Sequence Lengths
This invention relates to methods to prepare and compositions pertaining to branched ethylene-propylene copolymers that include at least 50% ethylene content...
2016/0122451 ENZYME-CATALYZED SYNTHESIS OF SITE-SPECIFIC AND STOICHIOMETRIC BIOMOLECULE-POLYMER CONJUGATES
Methods for producing polypeptide-polymer conjugates include attachment of an initiator agent to a polypeptide specifically at the C-terminus of the...
2016/0122450 SYNTHESIS OF A SUBSTITUTED FURAN
The present invention provides a polymer comprising an aliphatic backbone having a plurality of aromatic rings bonded thereon, said plurality of aromatic rings...
2016/0122449 POLYPROPYLENE FOR FILM APPLICATIONS
Propylene copolymer having a comonomer content in the range of 2.5 to 11.5 mol.-% and a melt flow rate MFR.sub.2 (230.degree. C.) in the range of 1.0 to 16.0...
2016/0122448 POLYETHYLENE COMPOSITION FOR PIPE AND PIPE COATING APPLICATIONS
The present application relates to a polyethylene composition comprising a base resin being a copolymer of ethylene with at least one alpha olefin comonomer...
2016/0122447 POLYMERIC ACID CATALYSTS AND USES THEREOF
Polymers useful as catalysts in non-enzymatic saccharification processes are provided. Provided are also methods for hydrolyzing cellulosic materials into...
2016/0122446 REVERSIBLE HEPARIN MOLECULES AND METHODS OF MAKING AND USING THE SAME
Methods and systems for synthesizing heparin compounds are provided. The chemoenzymatic synthesis of structurally homogeneous low molecular weight heparins...
2016/0122445 ENZYMATICALLY POLYMERIZED GELLING DEXTRANS
Compositions are disclosed herein comprising dextran that comprises (i) 87-93 wt % glucose linked at positions 1 and 6; (ii) 0.1-1.2 wt % glucose linked at...
2016/0122444 CHITIN-GLUCAN COMPLEXES AND METHOD FOR THE PREPARATION THEREOF FROM CHITIN-RICH BIOMATERIALS
The present invention is related to a novel process for the preparation of chitin-glucan or chitosan-glucan complexes from raw materials of biological origin...
2016/0122443 PROCESS FOR THE REMOVAL OF CONTAMINATION FROM A RAW MATERIAL
The present invention relates to a process for the removal of contamination from a raw material comprising a desirable material, such as chitin and/or...
2016/0122442 Process for Hydrolysis of Starch
The present invention relates to a process for enzymatic hydrolysis of granular starch into a soluble starch hydrolysate at a temperature below or just above...
2016/0122441 CATIONIC GROUP-CONTAINING CELLULOSE ETHER
Provided is a cationic group-containing cellulose which, when incorporated in a hair wash composition, is able to give an excellent smootheness feeling and its...
2016/0122440 MODIFIED WOOD FIBRES FOR MANUFACTURE IN COMPOSITES
A method for the acylation of lignocellulose by exposing the lignocellulose to an acylation agent in a closed vessel.
2016/0122439 ANTI-DLL4/VEGF DUAL VARIABLE DOMAIN IMMUNOGLOBULIN AND USES THEREOF
Disclosed herein are multivalent and multispecific binding proteins, methods of making the binding proteins, and their uses in the diagnosis, monitoring,...
2016/0122438 MONOSPECIFIC AND BISPECIFIC ANTI-IGF-1R AND ANTI-ERBB3 ANTIBODIES
Provided are monospecific and bispecific antibodies that are useful as anti-neoplastic agents and that bind specifically to human IGF-1R and human ErbB3....
2016/0122437 ANTIBODIES TO MATRIX METALLOPROTEINASE 9
The present disclosure provides compositions and methods of use involving binding proteins, e.g., antibodies and antigen-binding fragments thereof, that bind...
2016/0122436 SINGLE CHAIN BINDING MOLECULES COMPRISING N-TERMINAL ABP
The present invention relates to a single chain binding molecule comprising at least three binding domains, wherein the first binding domain is capable of...
2016/0122435 METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS
The present invention relates to immunoglobulins that bind Fc.gamma.RIIb+ cells and coengage the antigen on the cell's surface and an Fc.gamma.RIIb on the...
2016/0122434 ANTAGONIST OF THE BTLA/HVEM INTERACTION FOR USE IN THERAPY
The present invention relates to an antagonist of the BTLA/HVEM interaction for use in therapy, wherein said antagonist increases the proliferation of...
2016/0122433 ANTI-PDGFR-BETA ANTIBODIES AND USES THEREOF
The present invention provides antibodies that bind to platelet derived growth factor receptor beta (PDGFR-beta) and methods of using the same. According to...
2016/0122432 ANTI-HER2 SINGLE DOMAIN ANTIBODIES, POLYPEPTIDES COMPRISING THEREOF AND THEIR USE FOR TREATING CANCER
The present invention relates to anti-HER2 single domain antibodies, polypeptides comprising thereof and their use for treating cancer.
2016/0122431 B7-DC BINDING ANTIBODY
An antibody capable of potentiating immune responses and modifying existing states of immune responsiveness is described, as is the sequence of the antibody....
2016/0122430 ANTI-CS1 ANTIBODIES AND ANTIBODY DRUG CONJUGATES
The present disclosure provides antibodies and antibody drug conjugates that bind human CS1 and their uses to treat subjects diagnosed with a plasma cell...
2016/0122429 ANTI-TNF- / ANTI-IL-23 BISPECIFIC ANTIBODIES
Bispecific antibodies are provided that bind Tumor Necrosis Factor alpha (TNF.alpha.) and the p19 subunit of Interleukin-23 (IL-23p19) and are characterized as...
2016/0122428 FD CHAIN GENE OR L CHAIN GENE CAPABLE OF INCREASING SECRETION AMOUNT OF FAB-TYPE ANTIBODY
It is an object of the present invention to provide a method for producing a low-molecular-weight antibody such as a Fab-type antibody, using yeast as a host,...
2016/0122427 Protein Production Method
Production of etanercept using perfusion methods achieves attractive yields of properly folded protein. Desired temperature, feed media, titers and percent...
2016/0122426 ANTI-VEGF ANTIBODY, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING, DIAGNOSING OR TREATING CANCER OR...
A novel anti-vascular endothelial growth factor (VEGF) antibody having a strong binding affinity for VEGF and capable of inhibiting in vivo tumor growth and a...
2016/0122425 Activatable Binding Polypeptides and Methods of Identification and Use Thereof
Activatable binding polypeptides (ABPs), which contain a target binding moiety (TBM), a masking moiety (MM), and a cleavable moiety (CM) are provided....
2016/0122424 METHODS FOR TREATING DIABETES
Methods for treating diabetes by administering an inhibitor of GDF-8, or a related member of Transforming Growth Factor-beta (TGF-.beta.) superfamily of...
2016/0122423 BLOOD MARKERS FOR DIAGNOSING EPITHELIUM DERIVED CANCERS AND MONOCLONAL ANTIBODIES THEREOF
The present invention provides uses of cytokeratins as markers for diagnosing epithelium derived cancers. The present invention provides cancer-related...
2016/0122422 TREATMENT OF TAUOPATHIES
The invention is directed to methods of treatment of Alzheimer's disease and other tauopathies, via the administration of antibodies having specificity to...
2016/0122421 METHODS OF TREATING A TAUOPATHY
The present disclosure provides methods of treating a tauopathy, involving administering an anti-Tau antibody. The present disclosure also provides anti-Tau...
2016/0122420 ANTIBODY DISPLAY
The invention provides a protein comprising a first and a second copy of hepatitis B core antigen (HBcAg) in tandem, in which one or both of the copies of...
2016/0122419 ALTERNATIVE PATHWAY SPECIFIC ANTIBODIES FOR TREATING HEMOLYTIC DISEASES
A method of treating a hemolytic disorder in a subject in need thereof includes administering to the subject a therapeutically effective amount of an antibody...
2016/0122418 HUMAN MONOCLONAL ANTIBODY SPECIFIC FOR THE F PROTEIN OF RESPIRATORY SYNCYTIAL VIRUS (RSV)
This invention is directed to an antibody construct or fragment thereof derived from an RSV-infected human, such that the antibody construct binds with...
2016/0122417 Engineered Intein for Improved Production of Protein-Intein Fusions
The invention discloses engineered non-self-cleaving inteins derived from Mxe GyrA inteins and methods of using such inteins to chemically modify proteins.
2016/0122416 ANTIBODY COMPOSITION AND BUFFER SYSTEM THEREFOR
A method for conjugating an isolated antibody to a label or derivatisation reagent, which method comprises contacting the antibody with an activated label or...
2016/0122415 METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
The invention relates to a Myc dominant negative mutant, called Omomyc, for use in medicine and for use in the prevention and/or treatment of cancer. The...
2016/0122414 METHOD FOR EXTRACTING RECOMBINANT HUMAN SERUM ALBUMIN FROM TRANSGENIC RICE GRAIN
A method for extracting recombinant human serum albumin (rHSA) from transgenic rice grain is provided, comprising the steps of: 1) grinding dehusked rice...
2016/0122413 METHOD FOR PRODUCING ANTIBODY USING "NAKED" EXPRESSION VECTOR EXPRESSING TYPE II TRANSMEMBRANE FUSION PROTEIN
Methods are disclosed for generating antibodies and an expression vector used to express protein(s) which provoke the antibody response. The expression vector...
2016/0122412 COMPOSITION COMPRISED OF ANTIGEN LINKED TO A TNF SUPERFAMILY LIGAND
The invention provides fusion proteins comprising antigens of infectious disease agents and cancer cells linked to multiple-trimer forms of TNF SuperFamily...
2016/0122411 CARTILAGE-BINDING FUSION PROTEINS
Provided herein are fusion proteins comprising a first domain that specifically binds to the extracellular domain of a growth factor receptor, and a second...
2016/0122410 INTERFERON ALPHA 2B VARIANTS
The present invention provides a fusion polypeptide comprising a first domain and a second domain, wherein the first domain comprises a polypeptide ligand...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.